Director Peter Salzmann not standing for re-election; board size reduced to seven

Corbus Pharmaceuticals Holdings, Inc.

Dr. Salzmann will not stand for re-election at the 2025 annual meeting.
He continues as director and Nominating and Governance Committee member until the meeting.
Decision was not due to any disagreement with the company.
Board size reduced from eight to seven effective after the annual meeting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Peter Salzmann

Director

CRBP · Corbus Pharmaceuticals Holdings, Inc.

Filed: March 21, 2025, 7:59 PM ET

Dr. Peter Salzmann advised the Board of Directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”) that he will not stand for re-election as a director of the Company at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter Salzmann departed as Director at Corbus Pharmaceuticals Holdings, Inc..

Action: will not stand for re-election
Role: Director

Exact text from the filing

Dr. Peter Salzmann advised the Board of Directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”) that he will not stand for re-election as a director of the Company at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”).

View on SEC.gov

Corbus Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-043276

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.